Rheumatic and musculoskeletal diseases (RMDs) represent one of the more burdensome chronic diseases affecting around 25% of EU citizens of all ages.
The European League Against Rheumatism (Eular) says that, beyond the impact on individuals, RMDs impose an enormous burden on European societies, particularly in terms of productivity loss, as well as in terms of health care and social security costs.
“In order to address the enormous health and financial challenges imposed by RMDs and other chronic conditions, it is imperative that the EU and European countries further commit to finding effective, comprehensive solutions,” Eular recently said.
In this Event Report, EURACTIV will analyse how can we achieve a sustainable and effective EU health policy for citizens, focusing on chronic diseases and inclusion in social and economic life.
-
New EU Commission should take on rheumatic and musculoskeletal diseases
The new European Commission should tackle "head-on" rheumatic and musculoskeletal diseases, the president of the European League Against Rheumatism (Eular) told EURACTIV in an interview, referring to chronic diseases that affect one-quarter of all Europeans, creating healthcare and social security costs.
-
Health research is where the EU can leave a mark, lawmakers agree
Promoting medical research and innovation is the policy field where the European Union can really make a difference in tackling and preventing chronic diseases such as rheumatic and musculoskeletal diseases (RMDs), according to MEPs Roberta Metsola and Theresa Griffin.
-
Opportunity in a crisis: European Union must enable people with chronic conditions to remain active in social and economic life
The election of the new Parliament and the establishment of the new Commission represent an opportunity to re-calibrate the role of the EU in improving the health of its citizens. This debate, however, cannot be disconnected from a more general …
